Jan Unkelbach

Jan Unkelbach

Auto-generated profile, based on publicly available information

Jan Unkelbach

Department of Physics, University of Zürich, Zürich, Switzerland

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 December 2008 in Medical Physics
Verified
Journal Article
Closed access
JUJan Unkelbach
Jan Unkelbach
TBThomas Bortfeld
Thomas Bortfeld
BMBenjamin C. Martin
Benjamin C. Martin
MSMartin Soukup
Martin Soukup

1 November 2018 in Physics in Medicine & Biology
Verified
Journal Article
Closed access
PDF file
JUJan Unkelbach
Jan Unkelbach
MAMarkus Alber
Markus Alber
MBMark Bangert
Mark Bangert
RBRasmus Bokrantz
Rasmus Bokrantz
TCTimothy C Y Chan
Timothy C Y Chan
HXHuijun Xu
Huijun Xu
Motion and uncertainty in radiotherapy is traditionally handled via margins. The clinical target volume (CTV) is expanded to a larger planning target volume (PTV), which is irradiated to the prescribed dose. However, the PTV concept has several limitations, especially in proton therapy. Therefore, robust and probabilistic optimization methods have been developed that directly incorporate motion and uncertainty into treatment plan optimization for intensity modulated radiotherapy (IMRT) and intensity modulated proton therapy (IMPT). Thereby, the explicit definition of a PTV becomes obsolete and treatment plan optimization is directly based on the CTV. Initial work focused on random and systematic setup errors in IMRT. Later, inter-fraction prostate motion and intra-fraction lung motion became a research focus. Over the past ten years, IMPT has emerged as a new application for robust planning methods. In proton therapy, range or setup errors may lead to dose degradation and misalignment of dose contributions from different beams – a problem that cannot generally be addressed by margins. Therefore, IMPT has led to the first implementations of robust planning methods in commercial planning systems, making these methods available for clinical use. This paper first summarizes the limitations of the PTV concept. Subsequently, robust optimization methods are introduced and their applications in IMRT and IMPT planning are reviewed.

26 April 2007 in Physics in Medicine & Biology
Verified
Journal Article
Closed access
JUJan Unkelbach
Jan Unkelbach
TCTimothy C Y Chan
Timothy C Y Chan
TBThomas Bortfeld
Thomas Bortfeld
Treatment plans optimized for intensity modulated proton therapy (IMPT) may be sensitive to range variations. The dose distribution may deteriorate substantially when the actual range of a pencil beam does not match the assumed range. We present two treatment planning concepts for IMPT which incorporate range uncertainties into the optimization. The first method is a probabilistic approach. The range of a pencil beam is assumed to be a random variable, which makes the delivered dose and the value of the objective function a random variable too. We then propose to optimize the expectation value of the objective function. The second approach is a robust formulation that applies methods developed in the field of robust linear programming. This approach optimizes the worst case dose distribution that may occur, assuming that the ranges of the pencil beams may vary within some interval. Both methods yield treatment plans that are considerably less sensitive to range variations compared to conventional treatment plans optimized without accounting for range uncertainties. In addition, both approaches--although conceptually different--yield very similar results on a qualitative level.

1 December 2016 in International Journal of Radiation Oncology - Biology - Physics (IJROBP)
Verified
Journal Article
Closed access
JUJan Unkelbach
Jan Unkelbach
PBPablo Botas
Pablo Botas
DGDrosoula Giantsoudi
Drosoula Giantsoudi
BGBram L. Gorissen
Bram L. Gorissen
HPHarald Paganetti
Harald Paganetti

6 January 2012 in Physics in Medicine & Biology
Verified
Journal Article
Closed access
WCWei Chen
Wei Chen
JUJan Unkelbach
Jan Unkelbach
ATAlexei Trofimov
Alexei Trofimov
TMThomas Madden
Thomas Madden
HKHanne Kooy
Hanne Kooy
DCDavid Craft
David Craft
We present a method to include robustness in a multi-criteria optimization (MCO) framework for intensity-modulated proton therapy (IMPT). The approach allows one to simultaneously explore the trade-off between different objectives as well as the trade-off between robustness and nominal plan quality. In MCO, a database of plans each emphasizing different treatment planning objectives, is pre-computed to approximate the Pareto surface. An IMPT treatment plan that strikes the best balance between the different objectives can be selected by navigating on the Pareto surface. In our approach, robustness is integrated into MCO by adding robustified objectives and constraints to the MCO problem. Uncertainties (or errors) of the robust problem are modeled by pre-calculated dose-influence matrices for a nominal scenario and a number of pre-defined error scenarios (shifted patient positions, proton beam undershoot and overshoot). Objectives and constraints can be defined for the nominal scenario, thus characterizing nominal plan quality. A robustified objective represents the worst objective function value that can be realized for any of the error scenarios and thus provides a measure of plan robustness. The optimization method is based on a linear projection solver and is capable of handling large problem sizes resulting from a fine dose grid resolution, many scenarios, and a large number of proton pencil beams. A base-of-skull case is used to demonstrate the robust optimization method. It is demonstrated that the robust optimization method reduces the sensitivity of the treatment plan to setup and range errors to a degree that is not achieved by a safety margin approach. A chordoma case is analyzed in more detail to demonstrate the involved trade-offs between target underdose and brainstem sparing as well as robustness and nominal plan quality. The latter illustrates the advantage of MCO in the context of robust planning. For all cases examined, the robust optimization for each Pareto optimal plan takes less than 5 min on a standard computer, making a computationally friendly interface possible to the planner. In conclusion, the uncertainty pertinent to the IMPT procedure can be reduced during treatment planning by optimizing plans that emphasize different treatment objectives, including robustness, and then interactively seeking for a most-preferred one from the solution Pareto surface.

1 April 2018 in Seminars in Radiation Oncology
Verified
Journal Article
Closed access
JUJan Unkelbach
Jan Unkelbach
HPHarald Paganetti
Harald Paganetti